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Antihistomonal effects of artemisinin and Artemisia annua
extracts in vitro could not be confirmed by in vivo
experiments in turkeys and chickens
I. C. N. Thøfner1*, D. Liebhart2, M. Hess2, T. W. Schou3, C. Hess2, E. Ivarsen4, X. C. Frette´4,
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1Department of Veterinary Disease Biology, Faculty of Health and Medical Science, University of Copenhagen,
Frederiksberg C, Denmark, 2Clinic for Avian, Reptile and Fish Medicine, Department for Farm Animals and Veterinary
Public Health, University of Veterinary Medicine, Vienna, Austria, 3Environment and Toxicology, DHI, Hoersholm,
Denmark, 4Institute of Chemical Engineering, Biotechnology and Environmental Technology, Faculty
of Engineering, University of Southern Denmark, Odense, Denmark, 5Department of Food Science, Aarhus University,
A˚rslev, Denmark, and 6Department of Animal Science, Aarhus University, Viborg, Denmark
Five different Artemisia annua-derived materials (i.e. dry leaves, pure artemisinin, and hexane, dichlor-
omethane or methanol extracts of leaves) were screened for their in vitro activities against six clonal cultures
of Histomonas meleagridis. Except for the methanol extract, all tested materials displayed in vitro activity
against all tested protozoal clones. Neither the dry plant material, extracts nor artemisinin showed any
antibacterial activity against the xenic bacteria accompanying the six H. meleagridis clones at concentration
levels identical to the antihistomonal setting. The dichloromethane extract of dry leaves (Ext-DCM)
(minimal lethal concentration1.0 mg/ml) and artemisinin (half-maximal inhibitory concentration1.295
mg/ml) had the most promising antihistomonal properties and were therefore subsequently tested in a
standardized experimental infection model in both turkeys and chickens infected with clonal H. meleagridis.
There were no differences between treatment groups, where all infected turkeys showed severe clinical
histomonosis and demonstrated severe typhlohepatitis typical for histomonosis. Consistent with the
infection model used, the infected chickens did not show any adverse clinical signs but contracted severe
lesions in their caeca 7 and 10 days post infection (d.p.i.), liver lesions were absent to mild after 7 d.p.i. and
progressed to severe lesions at 10 d.p.i.; thus no differences between treatment groups were observed. In
conclusion, neither artemisinin nor Ext-DCM was able to prevent experimental histomonosis in turkeys and
chickens at the given concentrations, which is contrary to the antihistomonal effect noticed in vitro even
though the same clonal culture was used. The results of this study therefore clearly demonstrate the
importance of defined in vivo experimentation in order to assess and verify in vitro results.
Introduction
Histomonosis is a parasitic disease in gallinaceous birds,
primarily affecting turkeys and chickens. It causes severe
lesions in the caecum and the liver and can lead to high
mortality rates, especially in turkeys (McDougald, 2005).
Infection with Histomonas meleagridis in poultry flocks
has re-emerged since the ban of effective treatments
(McDougald, 2005; Callait-Cardinal et al., 2007;
Stokholm et al., 2010).
Previously used drugs have not yet been replaced
resulting in an urgent need for new curative or prophy-
lactic treatments. Several in vitro and in vivo experimental
studies on chemotherapeutics have shown variable out-
comes in finding a new and efficient therapy against
H. meleagridis infections (Hu & McDougald, 2002;
Hafez & Hauck, 2006; Bleyen et al., 2009; Hafez et al.,
2010; Hauck et al., 2010b). Within recent years a trend
towards non-chemotherapeutic alternative means has
been set in the combat of histomonosis. Despite this
awareness there is still only a limited number of in vitro
studies on the effects of natural compounds on H.
meleagridis available (Zenner et al., 2003; Grabensteiner
et al., 2007, 2008; Hauck & Hafez, 2007; Arshad et al.,
2008; van der Heijden & Landman, 2008a). The situa-
tion is similar when it comes to evaluating the impact of
natural compounds on histomonosis in vivo (Duffy et al.,
2004, 2005; Hafez & Hauck, 2006; Grabensteiner et al.,
2008; van der Heijden & Landman, 2008b).
Artemisia annua has been used as an herbal infusion in
traditional Chinese medicine for treatment of fevers,
including malaria (Klayman, 1985). The sesquiterpene
lactone artemisinin is one of the main active compounds
of this medicinal plant and has been shown to be
effective against various Plasmodium spp., including
Plasmodium falciparum that causes the most severe
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form of malaria in humans (Qinghaosu Antimalaria
Coordinating Research Group, 1979). Artemisinin-based
combination therapies are presently recommended as
first choice for uncomplicated antimalarial treatment by
the World Health Organization (2010). Furthermore,
several studies have shown promising effects of artemi-
sinin against other pathogenic protozoa, including
poultry coccidia (Allen et al., 1997, 1998; Brisibe et al.,
2008; del Cacho et al., 2010). It has been demonstrated
that supplementation of different levels of dried A. annua
leaves in feed reduced the oocyst excretion in chickens
experimentally infected with Eimeria spp. (Allen et al.,
1997, 1998; Brisibe et al., 2008). Supplementing dried
leaves or leaf extracts directly into poultry diets is an
easy way to administer feed supplements in poultry
flocks.
Since the discovery of artemisinin as an antimalarial
drug several hypotheses on its mode of action have been
suggested. The most plausible mode of action may be
attributed to the cleavage of its endoperoxide bridge
(Klayman, 1985; Olliaro et al., 2001). An iron-dependent
mechanism leads to the cleavage of the endoperoxide
bridge, producing free radicals that selectively target and
inhibit the sarcoplasmic/endoplasmic reticulum Ca2+
ATPases pump (Eckstein-Ludwig et al., 2003). This
mechanism has also been proposed in avian Eimeria
spp., where inhibition of coccidian sarcoplasmic/endo-
plasmic reticulum Ca2+ ATPases was demonstrated
recently (del Cacho et al., 2010). The molecular basis of
metabolic processes in histomonads, such as if Ca2 -
dependent ATPases are present, has not yet been
reported. In addition, it has been suggested that artemi-
sinin disrupts the mitochondrial membrane in the
malaria parasite (Li et al., 2005). Recently, it was
demonstrated that artemisinin and its derivatives are
distributed to malarial mitochondria, where they induce
production of reactive oxygen species resulting in depo-
larization of the mitochondrial wall (Wang et al., 2010).
Therefore, one aim of the present study was to
investigate whether a panel of extracts of A. annua
leaves, as well as pure artemisinin, causes similar
antiprotozoal effects on H. meleagridis in vitro. Signifi-
cant inhibitory impact of the plant derivates on histo-
monads in vitro should be verified in vivo in a second
step. Recently established in vitro propagated clonal
cultures of H. meleagridis (Hess et al., 2006b) were
used for screening the compounds in vitro (Grabenstei-
ner et al., 2008) and to assess their effect in a
standardized experimental infection model in both
turkeys and chickens (Hess et al., 2006a).
Materials and Methods
In vitro experiments. H. meleagridis cultures. In the first experiment, six
different clonal cultures of H. meleagridis (Table 1) were used to
evaluate the effect of artemisinin and A. annua extracts. Clonal cultures
were established through micromanipulation (Hess et al., 2006b). The
screening was carried out on available low passage numbers of the
clonal cultures, since it is well known that pathogenicity declines with
increasing passages (Tyzzer, 1936; Hess et al., 2008). All experiments
were performed in 2 ml Eppendorf tubes using protozoal cultures
propagated for 48 h in Medium 199 supplemented with Earle’s salts,
L-glutamine, 25 mM HEPES, L-amino acids (M199; Gibco†, Invitro-
genTM, Lofer, Austria), 2 mg/ml rice starch (Sigma-Aldrich, Vienna,
Austria) and 15% foetal calf serum (Gibco†, InvitrogenTM) at 408C
prior to testing. Cell suspensions of 106 protozoa/ml were prepared by
counting the number of viable cells in a Neubauer counting chamber
(Bright-Line† haemocytometer; Hausser Scientific, Horsham, Pennsyl-
vania, USA, supplied by Sigma-Aldrich, Vienna, Austria) using Trypan
blue (0.4%) (Gibco†, InvitrogenTM, Lofer, Austria) to exclude non-
viable cells. After centrifugation at 500g for 5 min, the protozoa were
resuspended in M199 with 15% foetal calf serum without rice starch and
the cell concentration was adjusted to 106 protozoa/ml.
A. annua materials. Dry leaves from seed propagated Artemisia annua
(cv. Artemis, F2 seeds, Mediplant, Conthey, Switzerland) cultivated at
the Department of Food Science, Aarhus University, A˚rslev, Denmark
were finely ground before use. Artemisinin (purity99%) was obtained
from Xiang Xi Holley Pharmaceutical Co., Ltd (Shanghai, China).
Crude extracts from fresh thawed or dried A. annua leaves were made
using hexane, dichloromethane or methanol. The crude extracts were
filtered using a glass funnel and filter paper (AGF675, 400 mm, white
ribbon filter, ashless; Frisenette, Knebel, Denmark) and evaporated at
308C in vacuo using a rotary evaporator before the oily precipitate
(extract) was used in further experiments.
Artemisinin and extracts were suspended (artemisinin, 1000 mg/ml)
or dissolved (leaf extracts, 75 mg/ml) in dimethyl sulphoxide (DMSO)
(purity 99.9%; Merck, Darmstadt, Germany). These were kept as stock
solutions throughout the experiment. Dry leaf powder was put directly
into 2 ml Eppendorf tubes and suspended in 100 ml M199 with 15%
foetal calf serum prior to efficacy screening.
Experimental set-up. A test system previously described by
Grabensteiner et al. (2007) was used. For each tested clonal culture,
negative and positive controls were included, consisting of 105 protozoa/
ml in fresh culture medium without the addition of A. annua materials
(negative control) or with the addition of 0.4 mg/ml dimetridazole
(positive control). The concentration levels of the materials in the test
cultures were: dry leaf powder, 5, 10, 20, and 40 mg/ml; artemisinin, 5,
10, and 20 mg/ml; hexane extract (Ext-HEX), 500, 1000, and 1500 mg/
ml; dichloromethane extract (Ext-DCM), 500, 1000, and 1500 mg/ml;
and methanol extract (Ext-MeOH), 500, 1000, and 1500 mg/ml.
Furthermore, hexane, dichloromethane and methanol were tested at
0.15% and DMSO at 2% added to aliquots consisting of 105 protozoa/
ml in fresh culture medium to assess the maximal effect of solvents in
the test cultures.
Test cultures were put in 2 ml Eppendorf tubes and consisted of
100 ml compound solution ( stock solution diluted 1:10 with M199
with 15% foetal calf serum prior to inoculation), 800 ml culture medium
consisting of M199, 2 mg/ml rice starch, and 15% foetal calf serum and
100 ml cell suspension with 106 protozoa/ml, thus starting with 105
protozoa/ml in all test cultures. Eppendorf tubes were incubated at 408C
for 48 h. Protozoan multiplication in all samples was evaluated 24 and
48 h after inoculation by counting the number of viable cells as
described above. The mean of two counts was recorded for each
replicate. Complete inhibition was confirmed by inoculation of 100 ml
from the bottom of the respective cell suspension into 900 ml fresh
medium without addition of any test material, where they were
evaluated after 48 h of incubation at 408C. The lowest concentration
Table 1. Clonal H. meleagridis cultures used for screening of
antiprotozoal properties of artemisinin and A. annua extracts.
Clonal culture Abbreviation
Passage
numbers
Histomonas meleagridis/Chicken/
Hungary/5009-C2/05
Hm2 45 to 47
Histomonas meleagridis/Turkey/
Austria/2877-C3/05
Hm3 21 to 23
Histomonas meleagridis/Turkey/
Austria/5642-C4/05
Hm4 38, 40 to 41
Histomonas meleagridis/Turkey/
Austria/2922-C6/04
Hm6 24 to 26
Histomonas meleagridis/Chicken/
Austria/8175-C7/06
Hm7 19 to 21
Histomonas meleagridis/Turkey/
Germany/4114-C18/05
Hm18 110 to 112
488 I. C. N. Thøfner et al.
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for a given test material that led to complete inhibition in all clonal
cultures with no live or motile protozoa after 24 h of incubation was
determined as the minimal lethal concentration (MLC) (Grabensteiner
et al., 2007).
In a second experiment, the effects of Ext-DCM from thawed fresh A.
annua and dried leaves, respectively, against H. meleagridis/Turkey/
Austria/2922-C6/04 were compared. The tested concentrations were
500, 1000, and 1500 mg/ml for both extracts. The experimental set-up
and controls were as described above.
A third experiment was set up to determine the half-maximal
inhibitory concentration (IC50) of artemisinin, which is the concentra-
tion inhibiting 50% of the protozoal growth compared with the
untreated control. In a similar set-up to the first experiment, protozoa
from H. meleagridis/Turkey/Austria/2922-C6/04 were used to evaluate
the inhibitory properties of artemisinin. Concentrations of artemisinin
in the test solutions for determining the IC50 were 10
1, 2101, 4101,
102, 2102, 4102, 103, 2103, 4103, 104, 2104 and 4104 mM.
The IC50 was enumerated by graphical extrapolation using GraphPad
Prism† 5 for Windows (GraphPad Software, San Diego, California,
USA; www.graphpad.com).
Antibacterial effect. Bacteria present in the same monoeucaryotic
Histomonas cultures as in the antiprotozoal setting were isolated using
selective media*Columbia 5% sheep blood agar (aerobe, 378C for 24 h;
Biomerieux, Vienna, Austria), MacConkey agar (aerobe, 378C for 24 h;
LAB M, Heywood, Lancashire, UK), Chromocult† Coliform Agar
(aerobe, 378C for 24 h; Merck), Schaedler 5% sheep blood agar
(anaerobe, 378C for 24 h; Biomerieux), and Sabouraud Gentamycin
Chloramphenicol agar (aerobe, 428C for 48 h; Biomerieux)*and
biochemical characterization methods*that is, catalase test
(Bactident† Catalase; Merck) and Escherichia coli typing sera F1,
F21, F103 for avian pathogenic E. coli (O1, O2, O78; Veterinary
Laboratories Agency, New Haw, Addlestone, Surrey, UK).
The antibacterial activity was assessed using the disc diffusion
method (Bauer et al., 1966; Clinical and Laboratory Standards
Institute, 2008). Preparation of inoculum followed the Clinical and
Laboratory Standards Institute Direct Colony Suspension Method
(Clinical and Laboratory Standards Institute, 2008): therefore, colonies
from agar plates grown for 24 h were suspended in PBS (Gibco†,
InvitrogenTM) and bacteria were evenly spread over the surface of the
agar plates with sterile cotton swabs. Mueller Hinton plates (Biomer-
ieux) were used for E. coli and Proteus spp., whereas Columbia 5%
sheep blood agar plates were used for Streptococcus spp. and
Staphylococcus spp. Volumes of 20 ml of the test solutions in
concentrations identical to those in the first experiment were loaded
onto empty Sensi-discs (Oxoid Ltd, Cambridge, UK). Discs were loaded
with 20 ml PBS as negative controls or with 10 mg meropenem (Oxoid
Ltd) as positive controls.
Statistical analysis. All assays were performed in duplicate and repeated
independently three times. The data analysis and statistical calculations
were made using one-way analysis of variance followed by Tukey’s
multiple comparison test (GraphPad Prism† 5 for Windows; GraphPad
Software, San Diego, California, USA; www.graphpad.com). P50.05
was considered significant.
In vivo experiments. Based on the results from the in vitro experiments a
bird experiment was set up in order to investigate the effect of
artemisinin and Ext-DCM on a virulent clonal culture of H. meleagridis
(H. meleagridis/Turkey/Austria/2922-C6/04) in turkeys and chickens
(Table 2). Administration of artemisinin was done via feed and Ext-
DCM via drinking water.
Experimental birds and housing. Sixty-five 1-day-old turkey poults (Big
6; Aviagen Turkeys Ltd, Tattenhall, UK) were randomly split into five
groups with equal gender ratio (Groups I, II, III, IV and V) (Table 2).
One hundred 1-day-old specific pathogen free chicks (VALO; Lohmann
Tierzucht GmbH, Cuxhaven, Germany) were randomly split into four
groups (Groups VI, VII, VIII and IX) (Table 2). On the first day of life
all birds were individually marked using the SwiftackTM system (Heart-
land Animal Health Inc., Fair Play, Missouri, USA) before they were
housed in pens on deep litter (wood shavings) in rooms under negative
pressure. Birds without challenge infection were kept apart from the
challenged birds in order to prevent contamination. Medicated or
unmedicated water and feed were provided ad libitum.
All procedures performed on the birds were approved by the
institutional ethics committee and licensed by the Austrian Government
(licence number 68.205/0103-II/3b/2011).
Feed and A. annua extracts. Birds were supplemented with artemisinin
in the feed or A. annua extract in the drinking water according to their
groups (Table 2). Supplementation started at day 1 of life and was
continued throughout the experimental period. The dosage was
determined due to the obtained in vitro results and followed the
protocol of Grabensteiner et al. (2008), in which in vivo dosages were
calculated as two-fold of the MLC or IC50.
All feed, medicated and unmedicated, used in the investigation were
produced at the Department of Animal Science, Aarhus University,
Viborg, Denmark. The nutritional composition of the base diets was
adjusted according to the age of birds. Artemisinin (purity]99%;
Trademax Pharmaceuticals & Chemicals Co., Ltd, Shanghai, China)
was added to the diets in concentrations of 100 and 2600 mg/kg feed.
Thus, both turkey and chicken feed were split into an unmedicated base
diet, a diet supplemented with 100 mg/kg artemisinin and with 2600
mg/kg artemisinin.
Ext-DCM from dried A. annua leaves was dissolved in DMSO and
administered as follows: from day 1 of life until day 15, the turkeys of
Group I got drinking water supplied with 0.2% pure extract; from day
16 onwards the concentration was decreased to 0.1% due to reduced
water intake. The chickens of Group VI were supplied with 0.1% extract
in the drinking water from day 1 of life and onwards.
Infection of the birds with a clonal culture of H. meleagridis. At 14 days
old, the birds were infected with H. meleagridis/Turkey/Austria/2922-
C6/04 (Hess et al., 2006b) (in vitro passage 22). All turkey poults in
Groups I, II, III and IV received 3105 H. meleagridis by the cloacal
route using a conventional Eppendorf pipette. Birds of Group III died
or had to be euthanized before inoculation was undertaken (see below).
The chickens of Groups VI, VII and VIII were inoculated both orally
and cloacally with 3105 H. meleagridis. For the oral inoculation, a
crop tube placed on a syringe (1 ml Omnifix F solo; B. Braun
Table 2. Overview of bird species, treatments and challenge infection with H. meleagridis/Turkey/Austria/2922-C6/04.
Group Treatment Number of birds
Challenge inoculum 300,000
H. meleagridis
I Ext-DCM 0.2% in drinking water (days 1 to 15); 0.1%
(day 16 onwards)
15 turkeys Cloacally
II Artemisinin 100 mg/kg feed 15 turkeys Cloacally
III Artemisinin 2600 mg/kg feed 15 turkeys Cloacally
IV, infection control None 15 turkeys Cloacally
V, negative control None 5 turkeys None
VI Ext-DCM 0.1% in drinking water 30 chickens Orally and cloacally
VII Artemisinin 100 parts/106 in feed 30 chickens Orally and cloacally
VIII, infection control None 30 chickens Orally and cloacally
IX, negative control None 10 chickens None
Antihistomonal effects of artemisinin 489
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 So
uth
ern
 D
en
ma
rk
] a
t 1
8:1
2 0
4 O
cto
be
r 2
01
2 
Melsungen AG, Melsungen, Germany) was used. The required numbers
of H. meleagridis were adjusted into a volume of 300 ml Medium
19915% foetal calf serum. Following inoculation, all birds were
deprived from feed and water for 5 h.
Examination of the birds and sampling procedures. All birds were
examined daily to detect any adverse clinical signs (e.g. diarrhoea,
anorexia, behavioural changes) and mortality. Feed and water con-
sumption were recorded daily. Body weight was measured weekly.
Cloacal swabs were taken three times a week starting prior to infection
in order to re-isolate and monitor the H. meleagridis excretion
according to the protocol described recently (Hess et al., 2006a). All
birds were sampled for blood once a week.
Euthanasia and post-mortem sampling. At 7 and 10 days post infection
(d.p.i.), 15 chickens from each infected group (Groups VI, VII and VIII)
and five chickens from the negative control (Group IX) were killed.
Turkeys that survived the challenge were killed at termination of the
experiment at 5 weeks of age (Hess et al., 2006a). Euthanasia due to
severe histomonosis or killing of chickens at specific time points was
performed by intravenous anaesthesia with thiopental followed by
bleeding.
Pathological examination was performed on all birds. Lesions
indicative for histomonosis in the caeca and the livers were noted
with scores ranging from 0 for no lesions to 4 describing the most severe
lesions, according to recently described protocols (Windisch & Hess,
2010; Zahoor et al., 2011).
Statistical analysis. Mortality data were analysed using the Gehan
BreslowWilcoxon test followed by the Bonferroni multiple comparison
test, with a sigificance level P50.05.
Results
In vitro experiments. Antiprotozoal effect. Antiprotozoal
properties after 48 h of incubation are presented in detail
in Table 3. For all treatments of the six clonal cultures,
the number of viable protozoa is presented as the mean
with standard deviations of the six replicates.
Addition of 5 mg dry leaf powder/ml did not result in
significant reduction in any of the six clonal cultures
(Hm2, Hm3, Hm4, Hm6, Hm7 and Hm18). In Hm3,
Hm6, Hm7 and Hm18, protozoal growth was signifi-
cantly lower at dry leaf powder levels of 10, 20 and 40
mg/ml. Hm2 showed a significant increase in protozoal
growth when treated with 5 or 10 mg/ml dry leaf powder.
Complete growth inhibition was seen at 20 and 40 mg/ml
in Hm2, Hm3, Hm6, Hm7 and Hm18, whereas complete
inhibition of cell proliferation was only seen at 40 mg/ml
dry leaf powder in Hm4. The MLC for dry leaf powder
was determined to 40 mg/ml after 24 h.
For artemisinin, complete inhibition of protozoa
proliferation was not observed in any of the six clonal
cultures at 24 or 48 h following incubation with different
concentrations (5, 10 and 20 mg/ml). However, signifi-
cant reductions of histomonads were noticed after
incubation for 48 h with artemisinin in the six cultures,
ranging from 56.5 to 95.3% for 5 mg/ml, 70.3 to 96.9% in
10 mg/ml and 83.7 to 96.8% in 20 mg/ml compared with
the untreated controls.
Growth of clonal cultures receiving 0.5 mg/ml Ext-
HEX was significantly reduced in Hm2, Hm3 and
Hm7, and the multiplication declined in all six clones
at concentrations of 1.0 and 1.5 mg/ml Ext-HEX
after 48 h. However, only 1.5 mg/ml resulted in complete
inhibition in the six clonal cultures at 24 h of incubation.
The MLC was determined to 1.5 mg/ml for Ext-HEX.
When adding Ext-DCM to the protozoa cultures, the
three tested concentrations (0.5, 1.0 and 1.5 mg/ml)
showed a significant inhibitory effect against histomo-
nads of all clones. Complete inhibition of the cultures
after 24 h of incubation was observed at Ext-DCM levels
of 1.0 mg/ml and 1.5 mg/ml (MLC1.0 mg/ml).
In contrast to the other two extracts (Ext-HEX and
Ext-DCM), Ext-MeOH was not able to induce complete
inhibition in any of the tested clonal cultures of H.
meleagridis. For Hm2, Hm3, Hm6 and Hm7 the growth
after 48 h at the three concentration levels was not
significantly different from the non-treated controls.
Only Hm4 was significantly inhibited after 48 h at the
three concentrations of 0.5, 1.0 and 1.5 mg/ml. A
significant increase in number of viable histomonads
was observed after addition of 0.5 mg/ml Ext-MeOH in
cultures of Hm18.
Comparison of two sources of Ext-DCM. The tested
concentrations of Ext-DCM extracted from dried
A. annua leaves showed the same pattern in inhibition
of H. meleagridis/Turkey/Austria/2922-C6/04 as Ext-DCM
extracted from fresh leaves. Similar MLCs were con-
firmed in both extracts (1 mg/ml), thus justifying the use
of dry leaf extracts in the in vivo study.
Determination of IC50 for artemisinin. The doseresponse
curve for artemisinin is shown in Figure 1, from which
the IC50 for artemisinin after 48 h was determined by
graphical interpolation to 4586 mM, which equals 1.295
mg/ml in test solution.
Antibacterial effect. In total, 19 bacterial strains were
isolated. E. coli strains (8/19) were isolated at least once
from all six H. meleagridis clonal cultures. E. coli
serotypes O1, O2, or O78 were isolated from Hm3,
Hm4, Hm6, and Hm7, Streptococcus spp. (5/19) were
isolated from Hm3, Hm4, Hm6, and Hm7, Proteus spp.
(5/19) were isolated from Hm2, Hm3, Hm4, and Hm18,
and one Staphylococcus sp. was isolated from Hm18.
No inhibitory effect of dry leaf powder, artemisinin,
Ext-HEX, Ext-DCM or Ext-MeOH was observed in any
of the 19 isolated bacterial strains from the six investi-
gated H. meleagridis clones.
In vivo experiments. Observations prior to challenge
infection. The birds in Groups I, II, IV and V showed
no decrease in activity, clinical signs or depression,
whereas turkeys administered artemisinin 2600 mg/kg
feed (Group III) started to show lower feed consumption.
At days 5 to 7 following feeding, seven out of 15 birds
from Group III died unexpectedly. At the same time, the
remaining birds of Group III displayed increasing
depression and anorexia and were therefore killed
humanely on day 7. Post-mortem findings in Group III
were: distended gallbladder (approximately 0.50.52
cm3; 15/15 birds), fatty-appearing pale liver (only present
in killed birds; 8/15 birds), enlarged kidneys with
increased tubular appearance (15/15 birds), urate depos-
its in ureters (15/15 birds), empty intestines (9/15 birds),
soft long bones (9/15 birds) and beaks (6/15 birds).
Furthermore, it was observed that the water contain-
ing 0.2% Ext-DCM had a very pronounced strong herbal
odour, which possibly decreased the intake of water of
those turkeys (Group I) at 2 weeks of age to 60 to 70%
490 I. C. N. Thøfner et al.
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Table 3. Results of the in vitro activities of artemisinin, A. annua dry leaves and extracts against six clonal cultures of H. meleagridis after a 48-h incubation period expressed in number of protozoal cells
Hm2 Hm3 Hm4 Hm6 Hm7 Hm18
Treatment
Mean and SDa
(104 protozoa)
Reductionb
(%)
Mean and SD
(104 protozoa)
Reduction
(%)
Mean and SD
(104 protozoa)
Reduction
(%)
Mean and SD
(104 protozoa)
Reduction
(%)
Mean and SD
(104 protozoa)
Reduction
(%)
Mean and SD
(104 protozoa)
Reduction
(%)
Control 70912.1 45914.4 5298.5 39914.2 5398.0 80921.5
DMSO 2% 64921.1 8.7 2593.5A 43.7 4594.9 13.4 29912.2 24.8 5099.3 5.0 100926.0 25.9
Dimetridazole 0.4 mg/ml 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0
Hexane 0.15% 73923.2 4.5 43914.8 3.6 39913.6 23.7 46913.3 18.5 5094.8 6.2 73910.9 8.7
Dichloromethane 0.15% 70919.7 0.2 40912.1 10.2 42918.8 17.7 40910.1 2.7 4992.7 8.2 66918.9 17.0
Methanol 0.15% 73919.9 5.4 34912.0 23.7 43911.3 16.3 4199.4 6.1 5099.6 4.9 86916.3 7.9
Dry plant 5 mg/ml 126927.4A 80.9 55918.6 21.8 63935.6 21.8 43945.5 10.4 6394.3 19.9 89923.9 11.5
Dry plant 10 mg/ml 100921.9A 43.5 795.1A 85.5 36925.5 29.9 9911.5A 75.9 27911.7A 48.4 21916.7A 74.0
Dry plant 20 mg/ml 090.0A 100.0 090.0A 100.0 090.2A 99.8 090.0A 100.0 090.0A 100.0 090.0A 100.0
Dry plant 40 mg/ml 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0
Artemisinin 5 mg/ml 1195.4A 83.7 591.9A 89.4 291.5A 95.3 593.0A 87.9 2399.7A 56.5 594.1A 94.2
Artemisinin 10 mg/ml 894.4A 88.1 391.8A 92.9 291.0A 95.6 393.1A 92.1 1695.0A 70.3 291.3A 96.9
Artemisinin 20 mg/ml 491.6A 94.7 291.1A 95.1 391.2A 93.9 392.3A 93.4 996.5A 83.7 391.8A 96.8
Ext-HEX 0.5 mg/ml 2897.8A 59.9 2196.1A 53.4 50929.6 2.8 3898.4 2.5 2799.7A 48.5 63925.9 21.5
Ext-HEX 1.0 mg/ml 090.0A 100.0 090.3A 99.6 090.1A 99.9 294.2A 95.6 090.0A 100.0 090.0A 100.0
Ext-HEX 1.5 mg/ml 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0
Ext-DCM 0.5 mg/ml 696.3A 91.9 594.6A 89.4 27913.8 47.2 597.6A 86.8 2598.0A 53.2 42920.7A 47.8
Ext-DCM 1.0 mg/ml 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0
Ext-DCM 1.5 mg/ml 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0 090.0A 100.0
Ext-MeOH 0.5 mg/ml 8899.9 26.6 5397.9 17.0 1994.5A 62.6 4396.3 11.4 5496.0 2.1 134922.9A 68.3
Ext-MeOH 1.0 mg/ml 80910.0 14.6 3897.0 16.5 2096.0A 61.2 3093.0 23.2 50910.1 4.6 107930.9 35.0
Ext-MeOH 1.5 mg/ml 71913.7 1.6 2293.8A 51.6 1593.0A 70.5 2399.3 41.7 4898.3 9.1 73918.5 8.2
aStatistical differences from clonal cultures without treatment are indicated with uppercase superscript letters (P50.05). Data were analysed using one-way analysis of variance followed by Tukey’s
multiple comparison test. SD, standard deviation.
bRelative reduction of protozoan cells in comparison with the untreated clonal culture. ‘‘ ’’ indicates an increase in growth compared with the untreated culture.
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compared with turkeys of the remaining groups. For
welfare reasons, based on the lower water consumption
the concentration of Ext-DCM was thereafter reduced
to 0.1% in Group I. No obvious differences in feed and
water consumption were observed between the groups of
chickens (Groups VI, VII, VIII and IX).
One turkey of Group IV (infected control group) died
at day 1 of age with no apparent post-mortem findings
or signs of infection. Two turkeys from Group I
(application of 0.2% Ext-DCM) died within 2 days after
challenge for reasons unrelated to histomonosis. One
chicken in the negative control group (Group IX) died at
3 days old showing neither significant pathological
lesions nor signs of bacterial infection.
Re-isolation of the parasite. No live histomonads were
recovered from turkeys or chickens prior to challenge
infection. From infected turkeys the protozoa were re-
isolated from cloacal swabs at 2 d.p.i. and onwards in all
infected groups (Groups I, II and IV). In Groups I and
IV, 100% of the birds excreted the parasite at least once
during the experiment. Similarly, 14 out of 15 turkeys of
Group II (application of 100 parts/106 artemisinin) had
positive re-isolations. No histomonads could be recov-
ered from any of the five turkeys in the negative control
group (Group V) throughout the experiment.
The excretion of histomonads from infected chickens
was observed starting at 2 d.p.i. The number of chickens
that were found positive by re-isolation at least once
were: Group VI (0.1% Ext-DCM), 14/30 birds; Group
VII (artemisinin 100 mg/kg feed), 12/30 birds; Group
VIII (infected control group), 16/30 birds; and the
negative control group (Group IX), 0/9 birds.
Morbidity, mortality and pathological findings in infected
turkeys. All infected turkeys (Groups I, II and IV)
showed various clinical signs of histomonosis, starting
with general depression and ruffled feathers. Later on,
sulphurous-coloured diarrhoea and sudden death be-
came obvious in the afore-mentioned groups. Birds
suffering from severe clinical signs were killed humanely.
The cumulative mortality of turkeys that died or were
killed due to histomonosis is shown in Figure 2. Two
birds from Group II (artemisinin 100 mg/kg feed) and
one from the infection control (Group IV) overcame the
clinical signs at 18 d.p.i. and were regarded as having
survived the challenge. Consequently, the experiment
was terminated at 20 d.p.i. by killing those three birds
and all turkeys of Group V.
Turkeys that died due to histomonosis displayed
severe disease-specific lesions in the caeca and livers.
Furthermore, necropsy of the three surviving turkeys
revealed severe lesions in the caeca and livers similar to
pathological changes of turkeys that died from the
disease. The lesion scores observed in the caeca and
livers are shown in Table 4.
None of the chickens in any of the infected groups
(Groups VI, VII and VIII) displayed clinical signs or
died due to histomonosis. Nevertheless, necropsy of the
chickens showed that the birds from the infected groups
(Groups VI, VII and VIII) had severe lesions (lesion
score3 to 4) in their caeca at 7 d.p.i. (see Table 4). On
the same day, the majority of the infected chickens had
no or mild gross lesions in the livers. Birds from the same
groups displayed severe caecal lesions on day 10 after
infection, which were accompanied by inflammation and
necrosis of the livers. Organs of non-infected chickens of
Group V were found normal during post-mortem
examination.
Discussion
The present in vitro experiment revealed significant dose-
dependent reductions in protozoal counts of all six
tested clones of H. meleagridis for the tested concentra-
tions of artemisinin and Ext-DCM.
In the first step, the direct effect of dried A. annua
leaves against mono-eukaryotic H. meleagridis was
investigated in an in vitro setting. Furthermore, it was
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Figure 1. Doseresponse curve of H. meleagridis/Turkey/Austria/
2922-C6/04 after 48 h of incubation with artemisinin (mean-
9standard deviation, n6).
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Figure 2. Cumulative mortality due to histomonosis of turkeys
challenged with H. meleagridis/Turkey/Austria/2922-C6/04.
Groups I and II were treated with A. annua extract of leaves
or artemisinin from the first day of life. Birds of Group IV were
kept untreated before all turkeys were challenged at week 2 of life.
Statistical difference between groups is indicated with different
uppercase letters (P50.05).
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aimed that in vitro investigations in this study could
deliver necessary data for a pre-selection of the tested
materials and concentrations that were most promising
for further in vivo testing.
As shown in Table 3 there are remarkably varying
properties, although dose dependent, both within a
clonal culture and between clones. In all six clonal
cultures a trend towards growth enhancement was seen
when adding 5 mg/ml dry leaf powder. This was only
significant in Hm2, however, where 5 mg/ml resulted in
80.9% increase in protozoa counts when compared with
the control within this clone. The increase in the number
of protozoa may partly be explained by the ability of the
in vitro cultivated H. meleagridis to use different starch
sources as demonstrated recently by Hauck et al.
(2010a), thus possibly also the starch fraction of
A. annua (Brisibe et al., 2009). A dose of 40 mg/ml dry
leaf powder was the only dosage that inhibited protozoal
multiplication in all six clonal cultures, thus resulting in
absolute death of the parasites after 24 and 48 h,
respectively.
With regard to artemisinin, the parent compound
isolated from A. annua, significant dose-dependent
reductions in protozoal counts were observed for all
six clones. Nevertheless, none of the concentrations was
able to induce a total inhibition of histomonad prolif-
eration. Hence, no MLC could be determined although
reduction rates ranged from about 85 to 95% for Hm2,
Hm3, Hm4, Hm6 and Hm18. Only a few in vitro studies
have tested artemisinin and not its derivatives against
protozoa, which were mainly intracellular parasites
assessed in cell cultures*for example, Toxoplasma
gondii (Nagamune et al., 2007; Hencken et al., 2010) or
Neospora caninum (Kim et al., 2002). For evaluation of
artemisinin IC50 values in vitro, two studies used
procedures comparable with the present set-up against
either Trichomonas vaginalis (Camuzat-Dedenis et al.,
2001) or Leishmania spp. (Sen et al., 2010). Sen
et al. (2010) obtained IC50 values on Leishmania spp.
at artemisinin levels of 100 to 120 mM. This supports, as
reviewed by White (2008) and Golenser et al. (2006), the
in vitro activity of artemisinin on other protozoa being in
the micromolar range. This concentration is consider-
ably higher than the effective dose against the malaria
parasite, which have IC50 values within the nanomolar
range. In our first experiment, no MLC could be
determined for artemisinin, and therefore the IC50 was
determined based on the in vitro results to 4586 mM. This
concentration is considerably higher than for malaria
parasites. H. meleagridis is relatively different from
obligate intracellular protozoa (e.g. Plasmodium spp.),
for example by having resistant or cyst-like stages
(Tyzzer, 1920; Zaragatzki et al., 2010) that may explain
the higher IC50.
Ext-DCM was the most effective leaf extract, display-
ing complete inhibition of protozoal multiplication at 1.0
mg/ml in all clonal H. meleagridis cultures. This was
superior to the Ext-MeOH, where no consistent inhibi-
tory patterns were noticed between the six clonal
cultures, and to some extent also the Ext-HEX, in which
the MLC was determined to 1.5 mg/ml for the six tested
H. meleagridis clones. This is in agreement with a recent
study reporting that dichloromethane extracts from four
different Artemisia spp. showed higher in vitro activity
against bloodstream forms of Trypanosoma brucei brucei
than methanol extracts from the same plant species
(Nibret & Wink, 2010). In addition to artemisinin and its
derivatives, A. annua extracts contain a range of essential
oil components (Nibret & Wink, 2010) and phenolic
compounds (Ferreira et al., 2010). Camphor and 1,8-
cineole were found to be the major components of A.
annua L essential oil (Charles et al., 1991), which are
capable of protecting chickens from pathological lesions
after experimental infection with Eimeria acervulina or
Eimeria tenella (Allen et al., 1997).
The comparison of Ext-DCM from dried A. annua
leaves against Ext-DCM from fresh thawed A. annua
leaves revealed identical MCLs, indicating similar in vitro
antihistomonal properties. Therefore, further experi-
ments were performed with the less laborious procedure
using extracts of dry leaves.
At present histomonads need accompanying bacteria
when cultured in vitro, but the role of the bacteria is not
clear (McDougald, 2005). In order to assess whether the
observed effects on H. meleagridis multiplication could
be accounted as a direct or indirect effect, an antibacter-
ial assay was performed on the accompanying xenic
bacterial culture from all six clonal H. meleagridis
cultures. No inhibitory effect on bacterial growth was
noticed when treated with dried A. annua leaves,
artemisinin or any of the three extract methods using
compound concentrations as in the screenings for
antihistomonal properties. It is known that artemether,
a derivative of artemisinin, has no antibacterial effect on
Table 4. Median hepatic and caecal lesion scores (LS) of turkeys suffering from histomonosis and of chickens at 7 and 10 d.p.i.
Turkeys Chickens
Mortality due
to histomonosis
(number of
birds)
Lesions specific
to histomonosis
(number of
birds)
Median LS
Mortality due
to histomonosis
(number of
birds)
Lesions specific
to histomonosis
(number of
birds)
Median LS
(7 d.p.i.)
Median LS
(10 d.p.i.)
Treatment Liver Caecum Liver Caecum Liver Caecum
0.2% (0.1%)
Ext-DCM
13/15 13/13 4 4 a     
0.1% Ext-DCM     0/30 30/30 0 4 3 4
Artemisinin
100 mg/kg feed
13/15 15/15 4 3 0/30 30/30 2 4 3 4
Infection control 13/14 14/14 4 3 0/30 30/30 0 4 3 4
Negative control 0/5 0/5 0 0 0/9 0/9 0 0 0 0
All birds were treated with artemisinin or A. annua leaf extract from first day of life and challenged at 2 weeks of age.
aNot applicable.
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human hospital strains of E. coli and Staphylococcus
aureus (Esimone et al., 2002). Similar investigations
found that artemisinin had no antibacterial effect on S.
aureus (Dhingra et al., 2000; Slade et al., 2009).
However, artemisinin showed antibacterial properties
at 1 mg/ml against E. coli, E. coli NCTC 9002 and
Proteus vulgaris (Dhingra et al., 2000). In our study, the
amount of artemisinin loaded onto the discs ranged
between 100 and 300 mg/disc (20 ml each test solution per
disc), which had no antibacterial effect on the bacterial
strains isolated from the clonal histomonal cultures. This
is in agreement with a study where no antibacterial effect
of 100 mg/disc artemisinin was found on E. coli or S.
aureus (Shoeb et al., 1990). To the best of our knowledge,
only a single study has addressed the antibacterial effect
of essential oil components extracted from A. annua
(Juteau et al., 2002). These authors demonstrated that
the oily extract showed no inhibitory effect on E. coli
and S. aureus, whereas complete inhibition was obtained
for Enterococcus hirae at 0.1 mg/ml. A few other studies
have been carried out on extracts of leaves from other
related Artemisia species describing large variations on
the inhibitory effect on E. coli, S. aureus and Proteus
spp. (Rabe & van Staden, 1997; Ahameethunisa &
Hopper, 2010; Seddik et al., 2010). The discrepancy
between the efficacies of extracts may be explained by
the different extraction methods, composition and purity
of the tested extracts. Furthermore, extracts from
different Artemisia species showing antibacterial effect
were tested in concentrations several times higher than
tested in the present work, in which a maximum of 10 to
30 mg extract per disc was used.
Combining the results of the antiprotozoal screening
with the antibacterial tests, it is reasonable to assume
that the observed inhibitory effect of dried A. annua
leaves, artemisinin, Ext-HEX and Ext-DCM, is attrib-
uted to a direct effect on histomonads and could be
regarded as antihistomonal. Ext-DCM and artemisinin
were found to have the strongest antihistomonal effect in
the in vitro studies and were therefore selected for further
in vivo testing.
Turkeys received the challenge dose only cloacally as
this is a proven route to establish infection in these birds
(Liebhart et al., 2008). Data about the comparative oral
or cloacal infection of chickens are not available, but it
was shown that a combination of both routes of
application with virulent histomonads caused severe
lesions in the caecum and/or the liver (Zahoor et al.,
2011). Therefore, chickens were infected via the crop and
cloaca in order to ensure a successful infection.
Despite treatment with the test substances, the clinical
outcome in turkeys was almost similar and of the same
severity as noticed for the untreated but infected turkeys.
Except three birds, all infected turkeys died or had to be
killed due to severe clinical conditions.
Severe lesions in the caeca were present in all infected
turkeys (median lesion score3 to 4) and chickens
(median lesion score4), except for two turkeys (Group
I) that were killed or died before the infection was
established. Severe liver lesions were dominant in all
infected turkeys regardless of treatment. In chickens, the
liver affection progressed from very mild at 7 d.p.i. to
severe at 10 d.p.i. independent of treatment. This
indicates that neither artemisinin nor Ext-DCM had
any protective effect on experimental histomonosis at the
administered dose levels.
A possible explanation for the discrepancy between in
vitro and in vivo efficacy of the present investigation is
not obvious. It can be speculated that the low bioavail-
ability (Titulaer et al., 1990) and the considerable self-
induced hepatic first-pass metabolism of artemisinins
seen in mammals (Gordi et al., 2005) may contribute
insufficient concentrations of artemisinins in the birds.
However, no information on the bioavailability and
metabolism is yet available in poultry or avian species.
An explanation for the difference in efficacy between P.
falciparum and H. meleagridis could be that artemisinin
and derivatives have a special affinity for malarial
mitochondria (Wang et al., 2010) and H. meleagridis
does not possess mitochondria (Lindmark & Mu¨ller,
1973). In the in vitro experiments, the effective doses of
artemisinin were in the micromolar range; therefore it
can be suggested that the amount of artemisinin or the
effective leaf extract fractions may have reached a level in
which sufficient and lethal ratios of free radicals were
obtained. Furthermore, no host interaction or metabo-
lism was disturbing the direct effect on H. meleagridis
when treated in vitro.
The post-mortem findings from the turkey group
administered artemisinin 2600 mg/kg feed (Group III)
may be indicative of intoxication, and further investiga-
tions are ongoing and will be discussed elsewhere.
Although very little information on the toxicological
profile of A. annua plant material and extracts, including
artemisinin, in poultry is available, it has recently been
investigated in broiler chickens (Arab et al., 2009;
Shahbazfar et al., 2011). Hepatic and renal degeneration
was seen histopathologically regardless of dose (17 to
136 mg/kg feed) after long-term oral administration of
artemisinin, whereas neuronal degeneration seemed to
be dose dependent, even though no clinical signs were
present (Shahbazfar et al., 2011). Furthermore, single
doses of 1250 mg/kg and 2500 mg/kg showed similar
patterns in clinical and histopathological findings, as
well as bile retention in the liver (Arab et al., 2009).
In conclusion, dry leaves and three extracts from A.
annua as well as the main antimalarial constituent of this
plant, artemisinin, were evaluated for the first time for
their antihistomonal activities in vitro against six differ-
ent clonal cultures of H. meleagridis. Four of the tested
materials displayed in vitro activity against all protozoal
clones. However, neither artemisinin nor Ext-DCM that
were tested in vivo was able to prevent experimental
histomonosis in turkeys or chickens at the given
concentrations, although the clonal culture used for
this investigation was one of the in vitro tested clones.
Thus, the results of this study clearly demonstrate the
importance of defined in vivo experiments in order to
assess and verify in vitro results.
Acknowledgements
Kamilla Mittermayr at the Clinic for Avian, Reptile and
Fish Medicine, Department for Farm Animals and
Veterinary Public Health, University of Veterinary
Medicine, Austria is thanked for taking good care of
the birds during the in vivo experiments. This work was
supported by The Strategic Research Council, Denmark
(FI. 2101-08-0048).
494 I. C. N. Thøfner et al.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 So
uth
ern
 D
en
ma
rk
] a
t 1
8:1
2 0
4 O
cto
be
r 2
01
2 
References
Ahameethunisa, A.R. & Hopper, W. (2010). Antibacterial activity of
Artemisia nilagirica leaf extracts against clinical and phytopathogenic
bacteria. BMC Complementary and Alternative Medicine, 10, 6.
Allen, P.C., Danforth, H.D. & Augustine, P.C. (1998). Dietary modula-
tion of avian coccidiosis. International Journal for Parasitology, 28,
11311140.
Allen, P.C., Lydon, J. & Danforth, H.D. (1997). Effects of components
of Artemisia annua on coccidia infections in chickens. Poultry Science,
76, 11561163.
Arab, H.A., Mardjanmehr, S.H., Shahbazfar, A., Rassouli, A.,
Abdollahi, M. & Nekouie, O. (2009). Toxicopathologic effects of
artemisinin in broiler chickens following a single oral dose: an LD50
study. International Journal of Poultry Science, 8, 808812.
Arshad, N., Zitterl-Eglseer, K., Hasnain, S. & Hess, M. (2008). Effect of
Peganum harmala or its beta-carboline alkaloids on certain antibiotic
resistant strains of bacteria and protozoa from poultry. Phytotherapy
Research, 22, 15331538.
Bauer, A.W., Kirby, W.M.M., Sherris, J.C. & Turck, M. (1966).
Antibiotic susceptibility testing by a standardized single disk method.
American Journal of Clinical Pathology, 45, 493496.
Bleyen, N., De Gussem, K., Pham, A.D.N., Ons, E., Van Gerven, N. &
Goddeeris, B.M. (2009). Non-curative, but prophylactic effects of
paromomycin in Histomonas meleagridis-infected turkeys and its
effect on performance in non-infected turkeys. Veterinary
Parasitology, 165, 248255.
Brisibe, E.A., Umoren, U.E., Brisibe, F., Magalhaes, P.M., Ferreira,
J.F.S., Luthria, D., Wu, X. & Prior, R.P. (2009). Nutritional
characterisation and antioxidant capacity of different tissues of
Artemisia annua L. Food Chemistry, 115, 12401246.
Brisibe, E.A., Umoren, U.E., Owai, P.U. & Brisibe, F. (2008). Dietary
inclusion of dried Artemisia annua leaves for management of
coccidiosis and growth enhancement in chickens. African Journal of
Biotechnology, 7, 40834092.
Callait-Cardinal, M.P., Leroux, S., Venereau, E., Chauve, C.M., Le
Pottier, G. & Zenner, L. (2007). Incidence of histomonosis in turkeys
in France since the bans of dimetridazole and nifursol. The Veterinary
Record, 161, 581585.
Camuzat-Dedenis, B., Provot, O., Cointeaux, L., Perroux, V.,
Berrien, J.F., Bories, C., Loiseau, P.M. & Mayraque, J. (2001).
Synthesis and in vitro trichomonacidal activities of some new
dialkylperoxides and 1,2,4-trioxanes. European Journal of Medicinal
Chemistry, 36, 837842.
Charles, D.J., Cebert, E. & Simon, J.E. (1991). Characterization of the
essential oil of Artemisia annua L. Journal of Essential Oil Research,
3, 3339.
Clinical and Laboratory Standards Institute. (2008). M31-A3 Perfor-
mance Standards for Antimicrobial Disk and Dilution Susceptibility
Tests for Bacteria isolated from Animals; Approved Standard-3rd
edition (28th ed., 8 vols.). Wayne, PA: Author (Formerly NCCLS).
del Cacho, E., Gallego, M., Francesch, M., Quilez, J. & Sanchez-Acedo,
C. (2010). Effect of artemisinin on oocyst wall formation and
sporulation during Eimeria tenella infection. Parasitology
International, 59, 506511.
Dhingra, V., Pakki, S.R. & Narasu, M.L. (2000). Antimicrobial activity
of artemisinin and its precursors. Current Science, 78, 709713.
Duffy, C.F., Sims, M.D. & Power, R.F. (2004). Preliminary evaluation of
dietary NatustatTM versus Histostat† (nitarsone) for control of
Histomonas meleagridis in broiler chickens on infected litter.
International Journal of Poultry Science, 3, 753757.
Duffy, C.F., Sims, M.D. & Power, R.F. (2005). Evaluation of dietary
NatustatTM for control of Histomonas meleagridis in male turkeys on
infected litter. Avian Diseases, 49, 423425.
Eckstein-Ludwig, U., Webb, R.J., van Goethem, I.D.A., East, J.M.,
Lee, A.G., Kimura, M., O’Neil, P.M., Bray, P.G., Ward, S.A. &
Krishna, S. (2003). Artemisinins target the SERCA of Plasmodium
falciparum. Nature, 424, 957961.
Esimone, C.O., Adikwu, M.U., Nwafor, S.V., Okoli, C.O., Ndu, O.O. &
Nwoke, O.I. (2002). In vitro antimicrobial interactions of arthemeter
with some 4-quinolones. Bollettino Chimico Farmaceutico, 141,
385388.
Ferreira, J.F.S., Luthria, D.L., Sasaki, T. & Heyerick, A. (2010).
Flavonoids from Artemisia annua L. as antioxidants and their
potential synergism with artemisinin against malaria and cancer.
Molecules, 15, 31353170.
Golenser, J., Waknine, J.H., Krugliak, M., Hunt, N.H. & Grau, G.E.
(2006). Current perspectives on the mechanism of action of
artemisinins. International Journal for Parasitology, 36, 14271441.
Gordi, T., Xie, R.J., Huong, N.V., Huong, D.X., Karlsson, M.O. &
Ashton, M. (2005). A semiphysiological pharmacokinetic model for
artemisinin in healthy subjects incorporating autoinduction of
metabolism and saturable first-pass hepatic extraction. British
Journal of Clinical Pharmacology, 59, 189198.
Grabensteiner, E., Arshad, N. & Hess, M. (2007). Differences in the in
vitro susceptibility of mono-eukaryotic cultures of Histomonas
meleagridis, Tetratrichomonas gallinarum and Blastocystis sp. to
natural organic compounds. Parasitology Research, 101, 193199.
Grabensteiner, E., Liebhart, D., Arshad, N. & Hess, M. (2008).
Antiprotozoal activities determined in vitro and in vivo of certain
plant extracts against Histomonas meleagridis, Tetratrichomonas
gallinarum and Blastocystis sp. Parasitology Research, 103, 1257
1264.
Hafez, H.M. & Hauck, R. (2006). Efficacy of a herbal product against
Histomonas meleagridis after experimental infection of turkey poults.
Archives of Animal Nutrition, 60, 436442.
Hafez, H.M., Hauck, R., Gad, W., De Gussem, K. & Lotfi, A. (2010).
Pilot study on the efficacy of paromomycin as a histomonostatic feed
additive in turkey poults experimentally infected with Histomonas
meleagridis. Archives of Animal Nutrition, 64, 7784.
Hauck, R., Armstrong, P.L. & McDougald, L.R. (2010a). Histomonas
meleagridis (Protozoa: Trichomonadidae): analysis of growth require-
ments in vitro. Journal of Parasitology, 96, 17.
Hauck, R., Fuller, A.L., Greif, G. & McDougald, L.R. (2010b).
Evaluation of nifurtimox for potential use in control of histomoniasis
in turkeys. Avian Diseases, 54, 2832.
Hauck, R. & Hafez, H.M. (2007). Effect of coated plant extracts on
Histomonas meleagridis and growth of bacteria in vitro. Avian
Diseases, 51, 880883.
Hencken, C.P., Jones-Brando, L., Bordon, C., Stohler, R., Mott, B.T.,
Yolken, R., Posner, G.H. & Woodard, L.E. (2010). Thiazole,
oxadiazole, and carboxamide derivatives of artemisinin are highly
selective and potent inhibitors of Toxoplasma gondii. Journal of
Medicinal Chemistry, 53, 35943601.
Hess, M., Grabensteiner, E. & Liebhart, D. (2006a). Rapid transmission
of the protozoan parasite Histomonas meleagridis in turkeys and
specific pathogen free chickens following cloacal infection with a
mono-eukaryotic culture. Avian Pathology, 35, 280285.
Hess, M., Kolbe, T., Grabensteiner, E. & Prosl, H. (2006b). Clonal
cultures of Histomonas meleagridis, Tetratrichomonas gallinarum and
a Blastocystis sp. established through micromanipulation.
Parasitology, 133, 547554.
Hess, M., Liebhart, D., Grabensteiner, E. & Singh, A. (2008). Cloned
Histomonas meleagridis passaged in vitro resulted in reduced patho-
genicity and is capable of protecting turkeys from histomonosis.
Vaccine, 26, 41874193.
Hu, J. & McDougald, L.R. (2002). Effect of anticoccidials and
antibiotics on the control of blackhead disease in broiler breeder
pullets. Journal of Applied Poultry Research, 11, 351357.
Juteau, F., Masotti, V., Bessiere, J.M., Dherbomez, M. & Viano, J.
(2002). Antibacterial and antioxidant activities of Artemisia annua
essential oil. Fitoterapia, 73, 532535.
Kim, J.T., Park, J.Y., Seo, H.S., Oh, H.G., Noh, J.W., Kim, J.H.,
Kim, D.Y. & Youn, H.J. (2002). In vitro antiprotozoal effects of
artemisinin on Neospora caninum. Veterinary Parasitology, 103, 5363.
Klayman, D.L. (1985). Qinghaosu (artemisinin)*an antimalarial drug
from China. Science, 228, 10491055.
Li, W., Mo, W.K., Shen, D., Sun, L.B., Wang, J., Lu, S., Gitscheir, J.M.
& Zhou, B. (2005). Yeast model uncovers dual roles of mitochondria
in the action of artemisinin. PLoS Genetics, 1, 329334.
Liebhart, D., Grabensteiner, E. & Hess, M. (2008). A virulent mono-
eukaryotic culture of Histomonas meleagridis is capable of inducing
fatal histomonosis in different aged turkeys of both sexes, regardless
of the infective dose. Avian Diseases, 52, 168172.
Antihistomonal effects of artemisinin 495
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 So
uth
ern
 D
en
ma
rk
] a
t 1
8:1
2 0
4 O
cto
be
r 2
01
2 
Lindmark, D.G. & Mu¨ller, M. (1973). Hydrogenosome, a cytoplasmic
organelle of anaerobic flagellate Tritrichomonas foetus, and its role in
pyruvate metabolism. Journal of Biological Chemistry, 248, 77247728.
McDougald, L.R. (2005). Blackhead disease (histomoniasis) in poultry:
a critical review. Avian Diseases, 49, 462476.
Nagamune, K., Beatty, W.L. & Sibley, L.D. (2007). Artemisinin induces
calcium-dependent protein secretion in the protozoan parasite
Toxoplasma gondii. Eukaryotic Cell, 6, 21472156.
Nibret, E. & Wink, M. (2010). Volatile components of four Ethiopian
Artemisia species extracts and their in vitro antitrypanosomal and
cytotoxic activities. Phytomedicine, 17, 369374.
Olliaro, P.L., Haynes, R.K., Meunier, B. & Yuthavong, Y. (2001).
Possible modes of action of the artemisinin-type compounds. Trends
in Parasitology, 17, 122126.
Qinghaosu Antimalaria Coordinating Research Group. (1979). Anti-
malaria studies on qinghaosu. Chinese Medical Journal, 92, 811816.
Rabe, T. & van Staden, J. (1997). Antibacterial activity of South African
plants used for medicinal purposes. Journal of Ethnopharmacology,
56, 8187.
Seddik, K., Nadjet, I., Abderrahmane, B., Daoud, H. & Lekhmici, A.
(2010). Antioxidant and antibacterial activities of extracts from
Artemisia herba alba Asso. leaves and some phenolic compounds.
Journal of Medicinal Plants Research, 4, 12731280.
Sen, R., Ganguly, S., Saha, P. & Chatterjee, M. (2010). Efficacy of
artemisinin in experimental visceral leishmaniasis. International
Journal of Antimicrobial Agents, 36, 4349.
Shahbazfar, A.A., Mardjanmehr, S.H., Arab, H.A., Rassouli, A. &
Abdollahi, M. (2011). Effects of artemisinin in broiler chickens
following chronic oral intake. Tropical Animal Health and Production,
43, 843849.
Shoeb, H.A., Tawfik, A.F., Shibl, A.M. & Elferaly, F.S. (1990).
Antimicrobial activity of artemisinin and its derivatives against
anaerobic bacteria. Journal of Chemotherapy, 2, 362367.
Slade, D., Galal, A.M., Gul, W., Radwan, M.M., Ahmed, S.A.,
Khan, S.I., Tekwani, B.L., Jacob, M.R., Ross, S.A. & Elsohly, M.A.
(2009). Antiprotozoal, anticancer and antimicrobial activities of
dihydroartemisinin acetal dimers and monomers. Bioorganic & Med-
icinal Chemistry, 17, 79497957.
Stokholm, N.M., Permin, A., Bisgaard, M. & Christensen, J.P. (2010).
Causes of mortality in commercial organic layers in Denmark. Avian
Diseases, 54, 12411250.
Titulaer, H.A.C., Zuidema, J., Kager, P.A., Wetsteyn, J.C.F.M.,
Lugt, C.B. & Merkus, F. W.H.M. (1990). The pharmacokinetics
of artemisinin after oral, intramuscular and rectal administra-
tion to volunteers. Journal of Pharmacy and Pharmacology, 42,
810813.
Tyzzer, E.E. (1920). The flagellate character and reclassification of the
parasite producing ‘‘Black Head’’ in turkeys Histomonas (Gen. Nov.)
meleagridis (Smith). Journal of Parasitology, 6, 124131.
Tyzzer, E.E. (1936). A study of the immunity produced by infection with
attenuated culture-strains of Histomonas meleagridis. Journal of
Comparative Pathology, 49, 285308.
van der Heijden, H.M.J.F. & Landman, W.J.M. (2008a). In vitro effect of
herbal products against Histomonas meleagridis. Veterinary
Parasitology, 154, 17.
van der Heijden, H.M.J.F. & Landman, W.J.M. (2008b). In vivo effect of
herbal products against Histomonas meleagridis in turkeys. Avian
Pathology, 37, 4550.
Wang, J., Huang, L.Y., Li, J., Fan, Q.W., Long, Y.C., Li, Y. & Zhou, B.
(2010). Artemisinin directly targets malarial mitochondria through its
specific mitochondrial activation. PLoS One, 5, A158A169.
White, N.J. (2008). Qinghaosu (Artemisinin): the price of success.
Science, 320, 330334.
World Health Organization. (2010). Guidelines for the Treatment of
Malaria (2nd ed.). Geneva http://whqlibdoc.who.int/publications/
2010/9789241547925_eng.pdf
Windisch, M. & Hess, M. (2010). Experimental infection of chickens
with Histomonas meleagridis confirms the presence of antibodies in
different parts of the intestine. Parasite Immunology, 32, 2935.
Zahoor, M.A., Liebhart, D. & Hess, M. (2011). Progression of
histomonosis in commercial chickens following experimental infec-
tion with an in vitro propagated clonal culture of Histomonas
meleagridis. Avian Diseases, 55, 2934.
Zaragatzki, E., Hess, M., Grabensteiner, E., Abdel-Ghaffar, F.,
Al-Rasheid, K.A.S. & Mehlhorn, H. (2010). Light and transmission
electron microscopic studies on the encystation of Histomonas
meleagridis. Parasitology Research, 106, 977983.
Zenner, L., Callait, M.P., Granier, C. & Chauve, C. (2003). In vitro
effect of essential oils from Cinnamomum aromaticum, Citrus
limon and Allium sativum on two intestinal flagellates of
poultry, Tetratrichomonas gallinarum and Histomonas meleagridis.
Parasite-Journal de la Socie´te´ Franc¸aise de Parasitologie, 10,
153157.
496 I. C. N. Thøfner et al.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 So
uth
ern
 D
en
ma
rk
] a
t 1
8:1
2 0
4 O
cto
be
r 2
01
2 
